Risedronate: a bisphosphonate with improved gastrointestinal tolerability New drugs and disease management 12 February 2013 Pages: 1 - 4
Is pegylated interferon-α plus ribavirin set to become the standard therapy for patients with hepatitis C? New drugs and disease management 12 February 2013 Pages: 5 - 8
Therapeutic drug monitoring — is it important for newer immunosuppressive agents? New drugs and disease management 12 February 2013 Pages: 8 - 12
Cancer-related anorexia/cachexia an ongoing challenge despite an increasing range of drug choices New drugs and disease management 12 February 2013 Pages: 12 - 15
First reports of adverse drug reactions (ADRs) in recent weeks Drug reactions and interactions 12 February 2013 Pages: 15 - 15